New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 28, 2013
10:15 EDTFURX, YOKU, AKRX, LGCY, PRGO, WU, ACAD, DVAOn The Fly: Analyst Initiation SummaryWestern Union
Today's noteworthy initiations include: Akorn (AKRX) initiated with a Sector Perform at RBC Capital... DaVita (DVA) initiated with a Market Perform at Bernstein... Perrigo (PRGO) initiated with a Sector Perform at RBC Capital... Youku Tudou (YOKU) initiated with a Buy at Deutsche Bank... ACADIA (ACAD) initiated with an Outperform at Cowen... Furiex (FURX) initiated with a Buy at Canaccord... Legacy Reserves (LGCY) initiated with a Buy at Ladenburg... PBF Energy (WU) initiated with a Buy at Dahlman Rose.
News For AKRX;DVA;PRGO;YOKU;ACAD;LGCY;FURX;WU From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
August 26, 2015
05:58 EDTPRGOPerrigo CEO says company is 'very active in M&A,' Bloomberg reports
Subscribe for More Information
August 25, 2015
13:51 EDTDVAU.S. Renal Care, DSI Renal announce merger agreement
Subscribe for More Information
13:22 EDTPRGOMylan comments on 'misleading' Perrigo statements
Subscribe for More Information
11:27 EDTPRGOTeva to refrain from voting at Mylan special meeting
Subscribe for More Information
09:59 EDTACADOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:07 EDTACADACADIA initiated with a Buy at Aegis
Subscribe for More Information
August 24, 2015
06:14 EDTDVADaVita to acquire Renal Ventures for $415M
Subscribe for More Information
August 21, 2015
16:38 EDTACADACADIA unit manufacturing agreement with BASF Pharma
On August 17, our Swiss subsidiary, ACADIA Pharmaceuticals GmbH, entered into a co-operation agreement and product schedule, collectively referred to as the manufacturing agreement, with BASF Pharma SA, or BASF. Under the manufacturing agreement, BASF has agreed to manufacture and supply pimavanserin tartrate, the active pharmaceutical ingredient of NUPLAZID, for commercial use. The term of the manufacturing agreement extends through December 31, 2020 and will automatically renew for subsequent one year terms unless either party provides timely notice of its intent not to renew, or unless the manufacturing agreement is terminated earlier pursuant to its terms.
15:22 EDTPRGOMylan clarifies certain inaccuracies related to lowered condition to acquire Perrigo
Subscribe for More Information
08:19 EDTPRGOMylan to host special shareholder meeting
Subscribe for More Information
August 20, 2015
10:00 EDTLGCYOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
10:00 EDTYOKUOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:20 EDTYOKUOn The Fly: Pre-market Movers
Subscribe for More Information
09:11 EDTYOKUYouku Tudou upgraded to Neutral following Q2 report at Mizuho
As previously reported, Mizuho upgraded Youku Tudou to Neutral from Underperform and maintained its $18 price target. The firm upgraded shares citing the Q2 beat and expects the consumer business to diversify and drive top line growth, and improve margin.
06:05 EDTYOKUYouku Tudou upgraded to Neutral from Underperform at Mizuho
05:36 EDTLGCYLegacy Reserves downgraded to Neutral from Buy at UBS
UBS downgraded Legacy Reserve (LGCY) to Neutral after after stress testing upstream MLPs to reflect scenarios in which oil remains depressed and recovery is limited. The firm expects MLPs that are better capitalized, well hedged and less levered to crude oil to outperform. It lowered its price target for shares to $5.50 from $14. UBS coupled the downgrade with an upgrade of Mid-Con Energy (MCEP) to Buy. Other Buy-rated upstream MLPs at the firm are Vanguard Natural (VNR), Memorial Production (MEMP) and Eagle Rock Energy (EROC). Sell-rated names are LINN Energy (LINE) and LinnCo (LNCO).
August 19, 2015
18:05 EDTYOKUYouku Tudou sees Q3 revenue RMB 1.69B-RMB 1.78B
Subscribe for More Information
18:04 EDTYOKUYouku Tudou reports Q2 EPS (RMB 1.76) vs. (RMB 0.76) last year
Subscribe for More Information
August 18, 2015
10:00 EDTYOKUOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:24 EDTYOKUYouku Tudou upgraded to Buy from Hold at T.H. Capital
T.H. Capital analyst Tian Hou upgraded Youku Tudou to Buy with a $33 price target. The company's Q2 results on August 20 should be solid and it is well positioned to benefit from the upcoming market consolidation, Hou tells investors in a research note.
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use